XML 16 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Unaudited Condensed Statements of Changes in Shareholders’ (Deficit) Equity - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Preference Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Sep. 30, 2024 $ 46 $ 144 $ 2,614,400 $ 250,396 $ 2,864,986
Balance (in Shares) at Sep. 30, 2024 458,000 1,437,500 [1]      
Accretion of carrying value to redemption value (2,614,400) (82,808) (2,697,208)
Net income (loss) 949,894 949,894
Balance at Mar. 31, 2025 $ 46 $ 144 1,117,482 1,117,672
Balance (in Shares) at Mar. 31, 2025 458,000 1,437,500 [1]      
Balance at Sep. 30, 2025 $ 46 $ 144 (625,463) (625,273)
Balance (in Shares) at Sep. 30, 2025 458,000 1,437,500 [1]      
Accretion of carrying value to redemption value (572,209) (572,209)
Term extension fee (900,000) (900,000)
Net income (loss) 31,067 31,067
Balance at Mar. 31, 2026 $ 46 $ 144 $ (2,066,605) $ (2,066,415)
Balance (in Shares) at Mar. 31, 2026 458,000 1,437,500 [1]      
[1] This number retroactively restated to include an aggregate of 187,500 Class B ordinary shares as a result of the underwriter’s full exercise of their over-allotment option on July 8, 2024. No Founder Shares are currently subject to forfeiture (see Note 5).